We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Convertible Catheter Opens Ureteral Obstructions

By HospiMedica International staff writers
Posted on 27 Dec 2016
Print article
Image: The ConvertX nephroureteral stent keeps the ureter open (Photo courtesy of BrightWater Medical).
Image: The ConvertX nephroureteral stent keeps the ureter open (Photo courtesy of BrightWater Medical).
An innovative nephroureteral stent (NS) system keeps the ureter patent, without the need for additional interventional procedures.

The ConvertX NS system for the treatment of ureteral obstructions enables interventional radiologists to eliminate a second invasive procedure to treat the patient. In conventional treatment, two separate interventional procedures are needed to treat the obstruction. The first uses standard interventional radiology techniques to insert a percutaneous nephrostomy catheter through the patient’s flank into the kidney; a drainage bag is then attached to the catheter. The second procedure, conducted 3–14 days later, involves removing the catheter and placing a NS to allow urine to be naturally voided.

The ConvertX System, in contrast, is implanted only once, and converts from a catheter to a NS in a brief office procedure, without the need for radiation or sedation, and all in under one minute. The ConvertX Stent then remains implanted in the patient, just like a standard internal ureteral stent. The ConvertX NS System is a product of BrightWater Medical (Murrieta, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

“Ureteral blockages due to kidney stones, tumors, or scarring from previous surgeries must be treated quickly so urine can be voided,” said Professor Bob Smouse, MD, founder and CEO of BrightWater Medical. “The ConvertX System saves the patient the risk and discomfort of an additional second interventional procedure and may reduce healthcare costs, free up the hospital’s angio suite for other procedures and save the IR procedural time that can be devoted to care of other patients.”

“The ConvertX System is the kind of technology advancement that we require to meet the dual goals of improving patient care and reducing the financial burden to the health care system,” said clinical associate professor of radiology James Benenati, MD, of the University of South Florida (USF, Tampa, USA). “Interventional radiology enables patients with severe ureteral blockages to be quickly treated, and technologies like the ConvertX platform provide the IR with simpler, more cost-effective solutions.”

Related Links:
BrightWater Medical
University of South Florida
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscopy Head Support
Reison 10-330

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.